Screener Summaries Updates Institutions Sign In More Updates › Other Events › ICCM Other Events · Jun 25, 2026
IceCure Medical Ltd. announced on June 25, 2026, that it has regained compliance with the Nasdaq minimum bid price… ICCM IceCure Medical Ltd.
IceCure Medical Ltd. announced on June 25, 2026, that it has regained compliance with the Nasdaq minimum bid price requirement. This announcement follows a period of non-compliance regarding the exchange's minimum share price standards. The company operates in the medical device industry, developing technologies for cryoablation.
More from IceCure Medical Ltd. IceCure Medical seeks shareholder approval for reverse splits up to 40-for-1 Nov 2, 2026 IceCure Medical director Yang Huang steps down; board seeks shareholder approval for executive equity grants Oct 5, 2026 AMA rejects permanent CPT code for cryoablation, citing premature transition Oct 5, 2026 On September 10, 2026, IceCure Medical Ltd. announced it received approval from China’s National Medical Products… Sep 10, 2026 On August 24, 2026, IceCure Medical Ltd. announced an exclusive distribution agreement with Scovas Medical for its… Aug 24, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
